POWRE: Novel Methods of Creating and Assessing Vascularized, Tissue-Engineered Constructs
POWRE: Novel Methods of Creating and Assessing Vascularized, Tissue-Engineered Constructs
批准号:
9973601
负责人:
Karen Burg
金额:
$7.5万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-10-01 至 2002-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
9973601BurgApproximately eight million surgical procedures are performed annually in the United States to treat individuals who have lost tissue or organs through a variety of disease processes and injuries. Tissue or organ loss is typically treated by transplantation from one individual to another, by surgical reconstruction, or by the use of mechanical devices. Unfortunately, these treatments may allow temporary repair only and may introduce further complications. Tissue engineering is the development of biological replacements, in which cells can be taken from the patient, expanded in culture, cultivated, combined with an absorbable polymer matrix, and implanted in the patient. Once implanted, the polymer gradually disappears as, in parallel, the tissue develops and gains form and function. Because the implanted cells are derived from the patient, the need for immunosuppression is eliminated, as are problems associated with traditional organ donation procedures. This research, with support from a POWRE award, will focus on novel methods of creating absorbable scaffolds to enhance vascularization potential and a novel, non-invasive method of assessing these sensitive constructs. The development of vasculature is critical to the progression of tissue engineering; since, currently the major impedance to developing viable, three-dimensional tissue is the challenge of providing a vascular support network. The study will address the precision patterning of absorbable scaffolds and the optimization of scaffold morphology, cell-scaffold interaction, and cellular distribution throughout the scaffold. The NSF POWRE funding is vital to establishing a record of independent research during the PI's transition from postdoctoral fellow to faculty.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF Engines Development Award: Advancing next generation agriculture in Southern Georgia (GA)
-
批准号:2303322
-
项目类别:Cooperative Agreement
-
资助金额:$100.0万
-
财政年份:2023
-
负责人:Karen Burg
-
依托单位:
I-Corps: Development of a wicking fiber cytometer for cell analysis applications
-
批准号:2041689
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2020
-
负责人:Karen Burg
-
依托单位:
I-Corps L: A Commercial Approach to Distribute Fused Research-Mentoring Modules
-
批准号:1547417
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2015
-
负责人:Karen Burg
-
依托单位:
EAGER: Building a Framework to Advance Research through Undergraduate Participation: Investigating pH in 3D Tissue Test Systems
-
批准号:1451319
-
项目类别:Standard Grant
-
资助金额:$6.99万
-
财政年份:2014
-
负责人:Karen Burg
-
依托单位:
EFRI-CBE: Emerging Frontiers in 3-D Breast Cancer Tissue Test Systems
-
批准号:0736007
-
项目类别:Standard Grant
-
资助金额:$200.0万
-
财政年份:2007
-
负责人:Karen Burg
-
依托单位:
Graduate Research Fellowship Program
-
批准号:0751278
-
项目类别:Fellowship Award
-
资助金额:$20.25万
-
财政年份:2007
-
负责人:Karen Burg
-
依托单位:
Innovations in Biomaterials
-
批准号:0139624
-
项目类别:Continuing Grant
-
资助金额:$29.99万
-
财政年份:2002
-
负责人:Karen Burg
-
依托单位:
PECASE: Analysis of Novel Composite Tissue Engineered Systems
-
批准号:0093805
-
项目类别:Standard Grant
-
资助金额:$37.5万
-
财政年份:2001
-
负责人:Karen Burg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: